CHA

Charles River Laboratories

GLP-certifiedAccepting studies

Full-service preclinical & GLP safety assessment, discovery to IND.

Preclinical / GLP laboratoryWilmington, MA, United StatesUnited StatesEst. 1947 · 79y21,000 staffWebsite

Open room Compare

Overview Capabilities Study capabilities Animal models Regulatory Locations Team

Animal-model database

Extensive model portfolio · 94

Illustrative — species, strains, disease models, regulatory acceptance & availability.

Species / strain	Model type	Disease area	Regulatory	Availability
DogBeagle	Outbred strain	General toxicology	FDA/EMA accepted	Limited · 600 cap.
MinipigGöttingen	Outbred strain	Dermal / ophthalmic	FDA/EMA accepted	Limited · 300 cap.
MouseC57BL/6	Inbred strain	Immunology	FDA/EMA accepted	Readily available · 20,000 cap.
MouseBALB/c	Inbred strain	—	FDA/EMA accepted	Readily available · 15,000 cap.
MouseNSG (NOD scid gamma)	Humanized	Immuno-oncology	Emerging	Readily available · 5,000 cap.
MouseCell-line xenograft (CDX)	Tumor xenograft	Oncology	Research-use	Readily available
MousePatient-derived xenograft (PDX)	Tumor xenograft	Oncology	Research-use	By request
Non-human primateCynomolgus macaque	Outbred strain	Biologics safety	FDA/EMA accepted	Limited · 1,500 cap.
RabbitNew Zealand White	Outbred strain	Repro / teratology	FDA/EMA accepted	Readily available · 2,000 cap.
RatSprague-Dawley	Outbred strain	General toxicology	FDA/EMA accepted	Readily available · 12,000 cap.
RatWistar Han	Outbred strain	—	FDA/EMA accepted	Readily available · 8,000 cap.

CHA

Charles River Laboratories

Preclinical / GLP · United States

Live record · illustrative seed data · scores deterministic, rules-based — not AI · regulatory signals are educational, not a compliance determination.